Angioimmunoblastic T-cell lymphoma overview: Difference between revisions
Created page with "__NOTOC__ {{Angioimmunoblastic T-cell lymphoma}} {{CMG}}; {{AE}} {{RT}} ==Overview== '''Angioimmunoblastic T-cell lymphoma (AILT)''' is a mature T-cell lymphoma chara..." |
No edit summary |
||
Line 11: | Line 11: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 12:21, 17 August 2015
Angioimmunoblastic T-cell lymphoma Microchapters |
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Angioimmunoblastic T-cell lymphoma overview On the Web |
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma overview |
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [3]
Overview
Angioimmunoblastic T-cell lymphoma (AILT) is a mature T-cell lymphoma characterized by a polymorphous lymph node infiltrate showing a marked increase in follicular dendritic cells (FDCs) and high endothelial venules (HEVs) and systemic involvement.[1] It is also known as immunoblastic lymphadenopathy (Lukes-Collins Classification) and AILD-type (lymphogranulomatosis X) T-cell lymphoma (Kiel Classification)[1].
References